跳至主要内容
临床试验/NCT07800819
NCT07800819尚未招募不适用

Surgical Outcomes and Long-Term Survival of Proximal Gastrectomy With Double-Tract Reconstruction at High-Volume Centers in Russia and China: A Two-Center Retrospective Analysis

The First Affiliated Hospital with Nanjing Medical University2 个研究点 分布在 2 个国家目标入组 250 人开始时间: 2026年8月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
250
试验地点
2
主要终点
Endoscopic reflux esophagitis

研究概览

简要总结

This two-center retrospective observational cohort study compares Chinese and Russian patients who underwent curative proximal gastrectomy with double-tract reconstruction for proximal gastric adenocarcinoma or Siewert type II/III adenocarcinoma of the esophagogastric junction. The study evaluates postoperative reflux, nutritional status, perioperative outcomes, complications, and long-term survival. Propensity score matching will be used to improve comparability between the two cohorts.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 to 75 years.
  • Histologically confirmed gastric adenocarcinoma or Siewert type II/III adenocarcinoma of the esophagogastric junction.
  • Underwent proximal gastrectomy with double-tract reconstruction.
  • Surgery performed with curative intent.
  • At least one valid postoperative follow-up record containing reflux, nutritional, or complication information.
  • Clinical, pathological, operative, and follow-up data sufficiently complete for analysis, with less than 20 percent missingness in key variables.

排除标准

  • Previous gastric or esophageal surgery, except limited endoscopic treatment such as endoscopic mucosal resection.
  • Synchronous or metachronous malignancy, except cured non-melanoma skin cancer or cervical carcinoma in situ.
  • Complete absence of follow-up data.
  • Double-tract reconstruction not completed or changed to another reconstruction method.
  • Severe preoperative reflux disease, defined as GERD-Q score greater than 8 with a requirement for long-term medication.

研究组 & 干预措施

Chinese cohort

Patients treated at the First Affiliated Hospital of Nanjing Medical University who underwent proximal gastrectomy with double-tract reconstruction during the study source period.

干预措施: Proximal gastrectomy with double-tract reconstruction (Procedure)

Russian cohort

Patients treated at the Moscow Clinical Scientific Center named after A.S. Loginov who underwent proximal gastrectomy with double-tract reconstruction during the study source period.

干预措施: Proximal gastrectomy with double-tract reconstruction (Procedure)

结局指标

主要结局

Endoscopic reflux esophagitis

时间窗: 1 year after surgery

Presence and severity of reflux esophagitis assessed by endoscopy using the Los Angeles classification (grades A-D).

Clinically significant reflux symptoms

时间窗: 1 year after surgery

Reflux symptoms assessed using the GERD-Q questionnaire; a total score greater than 8 is considered clinically significant reflux.

Change in body mass index

时间窗: From preoperative baseline to 1 year after surgery

Change in body mass index, measured in kilograms per square meter.

Change in serum albumin

时间窗: From preoperative baseline to 1 year after surgery

Change in serum albumin concentration, measured in grams per liter.

Change in hemoglobin

时间窗: From preoperative baseline to 1 year after surgery

Change in hemoglobin concentration, measured in grams per liter.

次要结局

  • Perioperative outcomes-Operative time(From surgery through hospital discharge, up to 6 months)
  • Postoperative complications(Within 30 days after surgery)
  • Overall survival(From the date of surgery until death or last follow-up, up to 12 years)
  • Disease-free survival(From the date of surgery until recurrence, death, or last follow-up, up to 12 years)
  • intraoperative blood loss(from surgery to discharge, up to 6 months)
  • postoperative length of hospital stay(from surgery to discharge, up to 6 months.)
  • conversion to open surgery(from surgery to discharge, up to 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hao Xu

Dr.

The First Affiliated Hospital with Nanjing Medical University

研究点 (2)

Loading locations...

相似试验